Kidney disease and cardiovascular risk could be better predicted with a simple blood test

A study led by the Institute of Cardiovascular and Medical Sciences, and published in Nature Medicine, has highlighted that a simple blood test is a better way of measuring both kidney and cardiovascular disease risk, as it offers a more precise diagnosis and could lead to better patient outcomes.Image of University of Glasgow buildings

Chronic kidney disease characterised by gradual loss of kidney function over time is common, affecting around 10% of the population. It is also associated with premature cardiovascular disease and mortality and more rarely progresses to the point where patients need dialysis or a kidney transplant.

Dr Jennifer Lees, Institute of Cardiovascular and Medical Sciences, said: “Our findings indicate that patients would benefit from the added predictive value of using a test called the cystatin C test. We would hope to see it adopted as the primary method for diagnosis of chronic kidney disease – particularly for those patients with cardiovascular disease risk factors such as diabetes, hypertension or obesity.”

A link to the study can be found here.

First published: 6 December 2019